Reuters logo
BRIEF-Cadila Healthcare says Zydus gets U.S. FDA approval for Donepezil hydrochloride tablets
September 1, 2017 / 5:55 AM / 4 months ago

BRIEF-Cadila Healthcare says Zydus gets U.S. FDA approval for Donepezil hydrochloride tablets

Sept 1 (Reuters) - Cadila Healthcare Ltd

* Says Zydus receives final approval from USFDA for Donepezil hydrochloride tablets

* Says drug will be manufactured at co’s formulations manufacturing facility at Moraiya, Ahmedabad

* Says drug is indicated for treatment of dementia of alzheimer’s disease

Source text - bit.ly/2vOCWbi

Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below